Overview
- Lilly’s once-daily pill Foundayo, approved Wednesday, will start free home shipping through LillyDirect on Monday with self-pay prices from $149 to $349 a month and insured patients eligible for $25 coupons and some Medicare copays of $50 this summer.
- Foundayo can be taken any time without food or water limits, and it is cleared for adults with obesity or for those who are overweight with weight-related conditions.
- Trial data show average weight loss of about 11% to 12% over roughly 16 to 18 months on the highest Foundayo dose, compared with higher averages reported for the Wegovy pill in separate studies and greater losses with weekly injections; the pills have not been tested head-to-head.
- Novo Nordisk, following Tuesday’s announcement, launched a Wegovy subscription that offers self-pay plans at $329 per month for three months, $299 for six months, or $249 for twelve months, with claimed annual savings up to $600 for the pill and $1,200 for injections via telehealth partners like Ro, Hims & Hers, WeightWatchers, LifeMD, and Sesame.
- England’s health watchdog NICE endorsed Wegovy to cut the risk of heart attack and stroke in high-risk adults, a decision Wednesday expected to open NHS access to roughly 1.2 million people based on a trial showing a 20% drop in major cardiovascular events.